Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |